• 23. Dezember 2024

ISA Pharmaceuticals Granted European Patent for the Intradermal Administration of ISA101

ByISA Pharmaceuticals BV

Mrz 24, 2015
#8722 Intradermal administration provides significant benefits compared to subcutaneous application
Teile den Beitrag mit Freunden

Kommentar verfassen